Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international
recommendations for PMR treatment are not currently available. In this paper, we report the …

To summarise evidence on therapeutic interventions and prognostic factors in polymyalgia
rheumatica (PMR). A systematic literature review was conducted using Ovid Medline …

Background Polymyalgia rheumatica (PMR) treatment is based on low-dose glucocorticoids.
Glucocorticoid-sparing agents have also been tested. Our objective was to systematically …

A systematic review and meta-analysis were conducted, according to the PRISMA
methodology, to summarize current evidence on the prevalence and predictors of long-term …

Objective Polymyalgia rheumatica (PMR) is the most common inflammatory rheumatic
disease in older people. Contemporary estimates of the incidence and prevalence are …

The objective of this study was to develop European League Against Rheumatism/American
College of Rheumatology classification criteria for polymyalgia rheumatica (PMR) …

Objective To compare current definitions of remission and relapse in polymyalgia
rheumatica (PMR) with items resulting from a Delphi-based expert consensus. Methods …

OBJECTIVE: This report summarizes the findings from a consensus process to identify
potential classification criteria for polymyalgia rheumatica (PMR). METHODS: A 3-stage …

Objective. To evaluate the incidence and risks of adverse events associated with therapy
(both corticosteroids [CS] and nonsteroidal antiinflammatory drugs [NSAIDs]) among a …

Polymyalgia rheumatica (PMR) is an inflammatory condition of unknown etiology
characterized by aching and stiffness in the shoulder and in the pelvic girdles and neck. In …